Nanostructured Materials for the Biomedical, Pharmaceutical, and Cosmetic Markets
The global market for nanoparticles used in biomedical, pharmaceutical and cosmetic applications increased from $170.7 million in 2006 to an estimated $204.6 million in 2007. It should reach $684.4 million by 2012, a compound annual growth rate (CAGR) of 27.3%.
Biomedical applications have the largest share of the market and are expected to account for 75.9% of the market in 2012.
Cosmetic applications are expected to lose market share over the next 5 years and account for just 22.8% of the market in 2012.
Nanotechnology has continued to develop rapidly in the 6 years since these three reports were published. In light of these developments, BCC Research decided to take a fresh look at the industry and reevaluate the existing and potential markets for nanoparticulate materials. The present report is an update of the 2001 report on biomedical, pharmaceutical, and cosmetic applications of nanoparticles.
There are a number of other published reports and studies covering various aspects of the market for nanoparticles and nanostructured materials. However, the literature lacks a comprehensive, up-to-date, and realistic technical market assessment that focuses on nanoparticles in biomedical, pharmaceutical, and cosmetic applications.
Since biomedical, pharmaceutical, and cosmetic applications are a major target market for many suppliers of nanoparticles and related technologies, BCC believes that this represents a significant gap in the recent literature. The primary objective of this report is to provide technological background, detailed industry information, and market data and forecasts through 2012, segmented by application and material type.
SCOPE OF STUDY
This report contains:
- Descriptions of various types of nanoparticles including nanoparticulate ceramics, metals, alloys, and semiconductors in the form of dry powders, liquid dispersions, coatings and bulk materials
- The current market status for nanoparticles, trends and forecasts for growth over the next 5 years
- Discussion of organic nanoparticles such as lipids and dendrimers that are expected to play a significant role in future applications
- Analysis of nanomaterials-related patents issued during the past 2 years
- Profiles of major and minor companies working with nanoparticles.
METHODOLOGY AND INFORMATION SOURCES
The data in this report were obtained from both primary and secondary sources. Executives, engineers, managers, researchers, and salespeople from companies and research institutions involved in the development, production, and/or usage of nanostructured particles were interviewed in the course of this study. Other data were obtained from an exhaustive review of patent literature and government databases, as well as scientific, trade, and business journals, and company literature. BCC newsletters, reports, and conferences provided additional information.
This report is an update of an earlier report prepared in 2001 by Mindy N. Rittner, Ph.D. Ms. Rittner, who holds a Ph.D. in Materials Science from Northwestern University, was formerly the Director of Nanotechnology Research at BCC. She was the founder and editor of BCC's monthly newsletter, Nanoparticle News, and the program chairwoman of BCC's former nanopowder conference.
The analyst responsible for updating the report is Andrew McWilliams, a partner in the Boston-based international technology and marketing consulting firm, 43rd Parallel, LLC. Mr. McWilliams is the author of several other BCC reports on nanomaterials and nanotechnologies, including Advanced Ceramics and Nano Ceramic Powders; Nanotechnology: A Realistic Market Assessment; Nanomaterials Markets by Type; and Nanotechnology in Life Sciences Applications.